Vaccinate before the next pandemic?

• Published in: Nature (London) Vol. 465; no. 7295; p. 161
• Main Author: Stoehr, Klaus
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 13.05.2010; Nature Publishing Group
• Subjects: 692/699/255/1578; 692/700/459; 692/700/478; 692/700/565/251/1567; Cost-Benefit Analysis; Developing countries; Disease Outbreaks - prevention & control; Disease Outbreaks - statistics & numerical data; Global Health; Humanities and Social Sciences; Humans; Immunization; Influenza Vaccines - administration & dosage; Influenza Vaccines - adverse effects; Influenza Vaccines - economics; Influenza Vaccines - supply & distribution; Influenza, Human - economics; Influenza, Human - epidemiology; Influenza, Human - prevention & control; Influenza, Human - transmission; LDCs; multidisciplinary; opinion; Pandemics; Science; Science (multidisciplinary); Time Factors; Vaccination - adverse effects; Vaccination - economics; Vaccination - methods; Vaccines

In March, the European Medicines Agency reported that since October more than 42 million Europeans, nearly half a million of whom were pregnant, had been vaccinated with one of the three pandemic vaccines authorized for use in the European Union, with no more adverse reactions than would be expected...